2026 NPPES data Ambulatory Care Pharmacist NPI 1154897619
Verify on CMS →

LINDA LUMINTAINTANG

Ambulatory Care Pharmacist in PALM SPRINGS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 277 beneficiaries · Ambulatory Care Pharmacist avg: 492
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

LINDA LUMINTAINTANG filed 2,283 Medicare Part D claims in 2023 as a Ambulatory Care Pharmacist in PALM SPRINGS, California, prescribing 52% generic.

2K
Part D claims, 2023
52%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LINDA LUMINTAINTANG's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,283 Top 15% higher than 85% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about LINDA LUMINTAINTANG?

Quality data not reported

NPI registry status

Active

Issued 10/22/2018

NPI 1154897619

Primary specialty

Ambulatory Care Pharmacist

Niche

3,473 US NPIs in this specialty

Medicare Part D claims

2,283 364% vs specialty avg

2023 prescription claims

Specialty avg: 492

Specialty distribution in California

How Ambulatory Care Pharmacist compares to other specialties among California providers

California providers

Ambulatory Care Pharmacist share within California

1. Ambulatory Care Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ambulatory Care Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Ambulatory Care Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ambulatory Care Pharmacist ABMS/AOA estimate

Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LINDA LUMINTAINTANG appears in the CMS NPPES registry as a Ambulatory Care Pharmacist provider at 255 N EL CIELO RD STE C326, PALM SPRINGS, CA, 92262, with a listed phone of (760) 969-6560. NPI 1154897619 was issued on 10/22/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LUMINTAINTANG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,283 prescription claims written by this provider, covering 277 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,473 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

255 N EL CIELO RD STE C326
PALM SPRINGS, CA 92262

Provider Details

NPI 1154897619
Specialty Ambulatory Care Pharmacist
Gender Female
NPI Issued 10/22/2018

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LINDA LUMINTAINTANG. To verify LINDA LUMINTAINTANG's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

LINDA LUMINTAINTANG — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 2,283 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,283
Total Claims
$1.0M
Total Drug Cost
277
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,694
Total Day Supply
138,506
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$978K
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
2.36
Gender Split
52% female / 48% male
Age Distribution
<65: 33, 65-74: 142, 75-84: 83, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LINDA LUMINTAINTANG prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
198
Soliqua 100-33
Insulin Glargine/Lixisenatide
195
Metformin Hcl
156
Trulicity
Dulaglutide
153
Ozempic
Semaglutide
131
Amlodipine Besylate
127
Jardiance
Empagliflozin
96
Losartan Potassium
71
Lisinopril
59
Humalog Kwikpen U-100
Insulin Lispro
53

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ambulatory Care Pharmacist Overview

How LINDA LUMINTAINTANG fits within the Ambulatory Care Pharmacist landscape nationally.

3,473
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
492
Avg Claims per Provider

LINDA LUMINTAINTANG's 2,283 claims are above the specialty average of 492.

Nearby Ambulatory Care Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LUMINTAINTANG.

Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LINDA LUMINTAINTANG's specialty?
LINDA LUMINTAINTANG specializes in Ambulatory Care Pharmacist and practices in PALM SPRINGS, California.
How much does LINDA LUMINTAINTANG prescribe under Medicare Part D?
In 2023, LINDA LUMINTAINTANG wrote 2,283 Medicare Part D claims totaling $1.0M in drug costs for 277 beneficiaries.
Where is LINDA LUMINTAINTANG located?
LINDA LUMINTAINTANG is located at 255 N EL CIELO RD STE C326, PALM SPRINGS, CA, 92262. Phone: (760) 969-6560.
What is LINDA LUMINTAINTANG's NPI number?
LINDA LUMINTAINTANG's National Provider Identifier (NPI) is 1154897619, issued on 10/22/2018.
Does LINDA LUMINTAINTANG prescribe more brand-name or generic drugs?
LINDA LUMINTAINTANG's prescribing is 48% brand-name and 52% generic drugs by claim count, with $978K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US?
There are 3,473 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 492 Medicare Part D claims per year.
What drugs does LINDA LUMINTAINTANG prescribe most often?
Based on 2023 Medicare Part D data, LINDA LUMINTAINTANG's most frequently prescribed drugs include Atorvastatin Calcium, Soliqua 100-33, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LINDA LUMINTAINTANG accept Medicare?
LINDA LUMINTAINTANG appears in CMS Medicare data with 2,283 Part D claims and 277 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LINDA LUMINTAINTANG's credentials?
LINDA LUMINTAINTANG's NPI is 1154897619. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology